INGN Q3 2020 Earnings — Inogen, Inc. Revenue & Financial Results | Market Cap Arena

INGNInogen, Inc.

$172M

Q3 2020 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$74M-19.0% YoY

Gross Profit

$33M44.4% margin

Operating Income

-$2M-2.7% margin

Net Income

-$2M-2.3% margin

EPS (Diluted)

$-0.08

QoQ Revenue Growth

+3.7%

Cash Flow

Operating Cash Flow

$7M

Free Cash Flow

$732,000

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$460M

Total Liabilities

$108M

Stockholders' Equity

$353M

Cash & Equivalents

$214M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$74M	$92M	-19.0%
Gross Profit	$33M	$43M	-23.8%
Operating Income	-$2M	$8M	-124.3%
Net Income	-$2M	$7M	-124.8%

Geographic Segments

UNITED STATES

$60M80%

Non Us

$15M20%